1,455
Views
13
CrossRef citations to date
0
Altmetric
Letter

Lenalidomide proved effective in multisystem Langerhans cell histiocytosis

, , , , , , , , , , & show all
Pages 412-415 | Received 21 Sep 2011, Accepted 01 Oct 2011, Published online: 21 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zdeněk Adam, Petr Szturz, Jiří Vaníček, Mojmír Moulis, Luděk Pour, Marta Krejčí, Roman Hájek & Jiří Mayer. (2013) Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. Acta Oncologica 52:5, pages 994-1001.
Read now

Articles from other publishers (12)

Gaurav Goyal, Abdellatif Tazi, Ronald S. Go, Karen L. RechJennifer L. Picarsic, Robert Vassallo, Jason R. YoungChristian W. Cox, Jan Van Laar, Michelle L. HermistonXin-Xin Cao, Polyzois Makras, Gregory Kaltsas, Julien HarocheMatthew CollinKenneth L. McClain, Eli L. Diamond & Michael Girschikofsky. (2022) International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 139:17, pages 2601-2621.
Crossref
Ronald S. GoEric JacobsenRobert BaiocchiIlia BuhtoiarovErin B. ButlerPatrick K. CampbellDon W. CoulterEli DiamondAron FlaggAaron M. GoodmanGaurav GoyalDita GratzingerPaul C. HendrieMeghan HigmanMichael D. HogartyFilip JankuReem KarmaliDavid MorganAnne C. RaldowAlexandra StefanovicSrinivas K. TantravahiKelly WalkovichLing Zhang, Mary Anne Bergman & Susan D. Darlow. (2021) Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 19:11, pages 1277-1303.
Crossref
Vitalii Dmitrievich Latyshev & E.A. Lukina. (2021) Langerhans Cell Histiocytosis in Adults: Treatment Opportunities of Today. Clinical oncohematology 14:4, pages 444-454.
Crossref
Zachary C. Gersey, Ian Zheng, Amade Bregy, Nitin Agarwal & Ricardo J. Komotar. (2020) Intracranial Langerhans cell Histiocytosis: A review. Interdisciplinary Neurosurgery 21, pages 100729.
Crossref
Endri Mauro, Piero Maria Stefani & Filippo Gherlinzoni. (2019) Adult Langerhans cell histiocytosis and immunomodulatory drugs: Review and analysis of thirty-four case reports. World Journal of Hematology 8:1, pages 1-8.
Crossref
Michael Girschikofsky & Abdellatif Tazi. 2018. Histiocytic Disorders. Histiocytic Disorders 139 153 .
Oussama Abla, Carlos Rodriguez-Galindo & Paul Veys. 2018. Histiocytic Disorders. Histiocytic Disorders 119 137 .
Ramya Uppuluri, Sreejith Ramachandrakurup, Ravikanth Balaji, Divya Subburaj, Atish Bakane & Revathi Raj. (2017) Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide. Journal of Pediatric Hematology/Oncology 39:2, pages e74-e78.
Crossref
Ramya Uppuluri, Sreejith Ramachandrakurup, Divya Subburaj, Atish Bakane & Revathi Raj. (2017) Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children. Pediatric Blood & Cancer 64:1, pages 110-112.
Crossref
Stephen C. Somach. 2016. Deadly Dermatologic Diseases. Deadly Dermatologic Diseases 23 28 .
Francesca M. Rizzo, Mauro Cives, Valeria Simone & Franco Silvestris. (2014) New Insights Into the Molecular Pathogenesis of Langerhans Cell Histiocytosis. The Oncologist 19:2, pages 151-163.
Crossref
Petr Szturz, Zdenek Adam, Zdenek Rehak, Renata Koukalova, Leos Kren, Mojmír Moulis, Marta Krejcí & Jiri Mayer. (2018) Salvage lenalidomide in four rare oncological diseases. Tumori Journal 99:5, pages e251-e256.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.